This series on “Small Cell Lung Cancer” is edited by Dr. Jose Pacheco, from Division of Medical Oncology, Department of Internal Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA.
In this series, we discuss the role for surgery in the management of Small Cell Lung Cancer (SCLC). We also discuss management of paraneoplastic syndromes and superior vena cava syndrome, two important comorbidities seen in SCLC. We would like to thank all the authors for their contributions to this special series and are confident it will help improve the readers’ understanding of SCLC.
PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches
The focused issue “Small Cell Lung Cancer” was commissioned by the editorial office, Journal of Thoracic Disease without any funding or sponsorship. Jose Pacheco is serving as the unpaid Guest Editor for the focused issue.